An Engineered Anisotropic Skeletal Muscle Organoid‐on‐a‐Chip for Deciphering Muscle Response under Intermittent Hypoxia
Jiao Li,Weihua Zhang,Anqi Liu,Yun Lu,Liming Yu,Xue Liu,Liangyan Sun,Bingjiao Zhao,Xianqin Tong,Tingjiao Liu,Yuehua Liu
DOI: https://doi.org/10.1002/adfm.202401564
IF: 19
2024-06-16
Advanced Functional Materials
Abstract:This study introduces a novel approach to construct functional skeletal muscle organoid‐on‐a‐chip by leveraging mechanical boundary constraints, yielding highly organized muscle structures and contractile functionality. The pathological model reveals adaptive and decompensatory responses of muscles under different intermittent hypoxia and serves as a reliable platform for drug screening, highlighting its potential in disease modeling and regenerative therapies. Generating highly organized skeletal muscle tissues that mimics the cellular alignment, maturation, and contraction of native skeletal muscle remains a challenge in disease modeling and regenerative therapies. Existing methodologies are constrained by complexity in fabrication and difficulty in achieving aligned 3D myofibers. Here, a functional skeletal muscle organoid‐on‐a‐chip (SMO) is engineered by establishing mechanical boundary constraints at either end of the cell‐laden extracellular matrix hydrogel within polydimethylsiloxane microstructures to promote the formation of an anisotropic biophysical microenvironment in tissues. The linearly aligned tissue, featuring multinucleated myofibers with distinct cross‐striations, exhibited a positive force‐frequency relationship and stable calcium transients under electrical stimulation. SMOs applicability is demonstrated by systematically evaluating muscle response to varying degrees of intermittent hypoxia. Murine‐ or human‐derived SMOs revealed that, with increasing hypoxia severity, muscles transitioned from a compensatory phase‐characterized by enhanced contractile function, vacuolation and hypertrophic‐like changes in myofibers, fiber type switching, and metabolic shift, to a decompensatory stage, paralleling in vivo muscle responses and highlighting interspecies differences. Human‐derived SMOs are also utilized to assess self‐repair capabilities and pharmaceuticals protective effects on damaged muscle. Together, the platform, with its simplicity of operation and reliable phenotypic readouts, demonstrates significant potential for future disease modeling and regenerative therapies.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology